IDentaIDTA 41 FCF Margin % is -6.42% as of Mar. 2026. GuruFocus rates IDTA with a GF Score™ of 41/100 and a GF Value™ of $0.32 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, IDenta ranks worse than 68.14% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. IDenta's Free Cash Flow for the
three
months ended in Mar. 2026 was $-0.04 Mil. IDenta's Revenue for the
three
months ended in Mar. 2026 was $0.55 Mil. Therefore, IDenta's FCF Margin % for the quarter that ended in Mar. 2026 was -6.42%.
The historical rank and industry rank for IDenta's FCF Margin % or its related term are showing as below:
IDTA'
s FCF Margin % Range Over the Past 10 Years
Min: -24.92 Med: 3.54 Max: 37.57
Current: -24.92
During the past 8 years, the highest FCF Margin % of IDenta was 37.57%. The lowest was -24.92%. And the median was 3.54%.
IDTA's FCF Margin % is ranked worse than 68.14% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.845
vs IDTA: -24.92
IDenta FCF Margin % Related Terms
IDenta FCF Margin % Historical Data
* Premium members only.
The historical data trend for IDenta's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, IDenta's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDenta FCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, IDenta's FCF Margin % distribution charts can be found below:
* The bar in red indicates where IDenta's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDenta (IDTA) has a FCF Margin % of -6.42% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on IDenta and its competitors. According to the industry distribution chart, IDenta ranks #139 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 68.1%.
Is IDenta's FCF Margin % too high?
IDenta's current FCF Margin % is -6.42%. Based on the distribution chart, IDenta ranks #139 out of 204 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, IDenta has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does IDenta's FCF Margin % compare to NSTM and PRPH?
According to the Medical Diagnostics & Research industry distribution chart, IDenta ranks #139 out of 204 companies for FCF Margin %. This places IDenta in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on IDenta and its competitors. IDenta's current FCF Margin % is -6.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDenta stock overvalued right now?
Based on GuruFocus' analysis, IDenta (IDTA) is currently considered Possible Value Trap. The stock's GF Value™ is $0.32, compared to a current price of $0.22 — trading 31.3% below its estimated fair value. The current FCF Margin % is -6.42%. IDenta's overall GF Score™ is 41/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For IDenta (IDTA), the current FCF Margin % is -6.42% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IDenta (IDTA) Overvalued in 2026?
Based on GuruFocus' analysis, IDenta stock appears to be undervalued.
The current stock price of $0.22 is trading 31.3% below its estimated GF Value™ of $0.32.
GuruFocus considers IDenta to be Possible Value Trap.
Key valuation signals for IDTA:
FCF Margin %: -6.42%
GF Value™: $0.32 vs. price of $0.22 (31.3% below fair value)
No single metric tells the full story. See the IDTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IDenta Corp is a detection and forensic science company. The firm, through its subsidiary, is engaged in the business of developing products to test for the presence of illegal drugs and explosives for law enforcement agencies, ports and border crossings, shipping hubs, and other organizations. Its product portfolio includes Drug testing kits, Explosive testing kits, Forensic products, Urine drug testing and others. The company currently sells its products to law enforcement organizations in the following countries: Indonesia, Argentina, Poland, France, USA, Spain, India, the United Kingdom, Ghana, Nigeria, Australia, Russia, Israel, Canada, Germany, Italy, and Portugal. The company also sells to retail markets in the United States, Italy, and South Africa.
41GF Score
Get the complete analysis for IDTA
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IDTA has been successfully added to your 
